- Lower volatility than the market (beta 0.52)
- Highly efficient cash conversion (100% FCF/OCF ratio)
- Beat earnings estimates in 2 of the last 4 quarters
Pharmacyt Biotch stock price up more than 6.50% on Monday
(Updated on Jun 15, 2026)
The Pharmacyt Biotch stock price gained 6.50% on the last trading day (Monday, 15th Jun 2026), rising from $0.761 to $0.81. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 8.51% from a day low at $0.774 to a day high of $0.84. The price has fallen in 4 of the last 10 days but is still up by 1.3% over the past 2 weeks. Volume fell on the last day by -37 thousand shares and in total, 133 thousand shares were bought and sold for approximately $108.03 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 8.78% during the next 3 months and, with a 90% probability hold a price between $0.770 and $1.06 at the end of this 3-month period.
PMCB Signals & Forecast
The Pharmacyt Biotch stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $0.732 and $0.767. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, June 05, 2026, and so far it has risen 15.79%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.
Support, Risk & Stop-loss for Pharmacyt Biotch stock
Pharmacyt Biotch finds support from accumulated volume at $0.790 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0659 between high and low, or 8.51%. For the last week the stock has had daily average volatility of 6.00%.
Our recommended stop-loss: $0.783 (-3.44%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 6 days ago.)
Trading Expectations (PMCB) For The Upcoming Trading Day Of Tuesday 16th
For the upcoming trading day on Tuesday, 16th we expect Pharmacyt Biotch to open at $0.81, and during the day (based on 14 day Average True Range), to move between $0.780 and $0.84, which gives a possible trading interval of +/-$0.0611 (+/-7.84%) up or down from last closing price. If Pharmacyt Biotch takes out the full calculated possible swing range there will be an estimated 7.84% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $0.81 (0.19%) than the support at $0.790 (2.53%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Pharmacyt Biotch stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Pharmacyt Biotch stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.
Current score:
3.315
Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on June 16, 2026 - $0.81 ( 0.284%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
PMCB Performance
Trading levels for PMCB
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.87 | 7.85% |
| R2 | 0.85 | 4.74% |
| R1 | 0.83 | 2.82% |
| Price | 0.81 | |
| S1 | 0.783 | -3.39% |
| S2 | 0.767 | -5.31% |
| S3 | 0.742 | -8.41% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.95 | 17.29% |
| R2 | 0.86 | 5.77% |
| R1 | 0.81 | 0.185% |
| Price | 0.81 | |
| S1 | 0.790 | -2.53% |
| S2 | 0.780 | -3.76% |
| S3 | 0.700 | -13.63% |
FAQ
Click here for our free guide on how to buy Pharmacyt Biotch Stock.
Buy PMCB